Axon Enterprise (NASDAQ:AXON) CEO Patrick Smith Sells 10,000 Shares of Stock

Axon Enterprise, Inc (NASDAQ:AXON) CEO Patrick Smith sold 10,000 shares of the business’s stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $643.79, for a total transaction of $6,437,900.00. Following the sale, the chief executive officer directly owned 3,040,997 shares of the company’s stock, valued at $1,957,763,458.63. This represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise Trading Down 3.0%

Shares of AXON traded down $17.80 during trading hours on Thursday, hitting $582.00. The stock had a trading volume of 1,024,829 shares, compared to its average volume of 1,112,986. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91. The firm has a market cap of $46.91 billion, a P/E ratio of 233.73, a P/E/G ratio of 13.07 and a beta of 1.38. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The company’s fifty day simple moving average is $451.08 and its 200 day simple moving average is $483.28.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. The firm had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.90 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm’s quarterly revenue was up 33.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.47 earnings per share. Equities research analysts forecast that Axon Enterprise, Inc will post 1.63 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Brighton Jones LLC bought a new position in Axon Enterprise during the 4th quarter valued at $480,000. NewEdge Advisors LLC lifted its position in shares of Axon Enterprise by 41.1% during the first quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock worth $1,207,000 after purchasing an additional 668 shares during the last quarter. Empowered Funds LLC grew its stake in Axon Enterprise by 8.4% in the first quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock worth $1,067,000 after purchasing an additional 157 shares in the last quarter. Woodline Partners LP increased its holdings in Axon Enterprise by 40.6% in the first quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock valued at $3,646,000 after buying an additional 2,003 shares during the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in Axon Enterprise during the second quarter valued at approximately $284,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

AXON has been the topic of several research reports. Piper Sandler restated an “overweight” rating and issued a $674.00 price target on shares of Axon Enterprise in a report on Monday, June 15th. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a research report on Monday. TD Cowen cut their target price on shares of Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a research note on Wednesday, April 8th. The Goldman Sachs Group set a $535.00 target price on shares of Axon Enterprise in a research note on Thursday, May 7th. Finally, UBS Group cut their price objective on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus target price of $722.12.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon was upgraded to Zacks Rank #1 (Strong Buy), signaling improved earnings expectations and a potentially supportive near-term setup for the stock. Article: Axon (AXON) Upgraded to Strong Buy: Here’s What You Should Know
• Positive Sentiment: Needham raised its view on Axon’s valuation, arguing the company’s premium could be sustainable because of its strong bookings trajectory and long-term growth profile. Article: Needham Bets Axon’s Premium Is Sustainable at $750
• Positive Sentiment: Recent coverage highlighted record quarterly revenue and expanding public-safety contract momentum, including a larger Los Angeles Police Department spend and ICE-related contract speculation, both of which support the growth narrative. Article: Why Axon Enterprise (AXON) Is Up 14.2% After Trump Stake And New ICE Contract Momentum
• Neutral Sentiment: AXON has also been getting heavier search attention from investors, which can indicate rising interest but does not by itself change fundamentals. Article: Investors Heavily Search Axon Enterprise, Inc (AXON): Here is What You Need to Know
• Negative Sentiment: Some coverage said Axon underperformed broader competitors in one recent session, and the stock’s rich valuation remains a point of caution for investors. Article: Axon Enterprise Inc. stock underperforms Wednesday when compared to competitors

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.